학술논문
1019P Pattern of clinical activity of anticancer vaccine OSE2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (IO) in phase III Atalante-1 randomized trial
Document Type
Abstract
Author
Source
In Annals of Oncology September 2022 33 Supplement 7:S1020-S1020
Subject
Language
ISSN
0923-7534